Perkins Capital Management’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $62.9K | Buy |
7,037
+250
| +4% | +$2.49K | 0.06% | 81 |
|
|
2025
Q4 | $56.6K | Sell |
6,787
-405
| -6% | -$4.09K | 0.04% | 88 |
|
|
2025
Q3 | $86.3K | Hold |
7,192
| – | – | 0.08% | 79 |
|
|
2025
Q2 | $61K | Hold |
7,192
| – | – | 0.06% | 76 |
|
|
2025
Q1 | $81.3K | Sell |
7,192
-205
| -3% | -$3.72K | 0.09% | 77 |
|
|
2024
Q4 | $151K | Sell |
7,397
-27,641
| -79% | -$806K | 0.13% | 74 |
|
|
2024
Q3 | $1.39M | Sell |
35,038
-3
| -0% | -$81 | 1.3% | 22 |
|
|
2024
Q2 | $617K | Buy |
35,041
+173
| +0.5% | +$2.93K | 0.58% | 55 |
|
|
2024
Q1 | $579K | Sell |
34,868
-125
| -0.4% | -$1.82K | 0.48% | 59 |
|
|
2023
Q4 | $661K | Buy |
34,993
+27,489
| +366% | +$516K | 0.56% | 53 |
|
|
2023
Q3 | $156K | Sell |
7,504
-500
| -6% | -$15.2K | 0.15% | 83 |
|
|
2023
Q2 | $437K | Sell |
8,004
-24,305
| -75% | -$747K | 0.38% | 63 |
|
|
2023
Q1 | $585K | Sell |
32,309
-318
| -1% | -$5.48K | 0.55% | 54 |
|
|
2022
Q4 | $331K | Buy |
32,627
+1,237
| +4% | +$13.2K | 0.35% | 67 |
|
|
2022
Q3 | $414K | Sell |
31,390
-4,115
| -12% | -$62.3K | 0.46% | 60 |
|
|
2022
Q2 | $458K | Sell |
35,505
-2,042
| -5% | -$54K | 0.47% | 61 |
|
|
2022
Q1 | $1.95M | Buy |
37,547
+10,665
| +40% | +$452K | 1.6% | 25 |
|
|
2021
Q4 | $1.21M | Buy |
26,882
+6,894
| +34% | +$369K | 0.82% | 44 |
|
|
2021
Q3 | $1.31M | Sell |
19,988
-5,236
| -21% | -$397K | 0.81% | 41 |
|
|
2021
Q2 | $2.52M | Sell |
25,224
-578
| -2% | -$59.6K | 1.43% | 24 |
|
|
2021
Q1 | $3.29M | Buy |
25,802
+3,462
| +15% | +$512K | 1.9% | 15 |
|
|
2020
Q4 | $2.48M | Buy |
22,340
+5,574
| +33% | +$624K | 1.62% | 16 |
|
|
2020
Q3 | $1.97M | Buy |
+16,766
| New | +$2.9M | 1.81% | 15 |
|
|
2020
Q1 | $1.98M | Buy |
8,781
+2,023
| +30% | +$577K | 2.39% | 11 |
|
|
2019
Q4 | $1.81M | Sell |
6,758
-842
| -11% | -$212K | 1.63% | 16 |
|
|
2019
Q3 | $2.31M | Sell |
7,600
-1,062
| -12% | -$326K | 1.99% | 12 |
|
|
2019
Q2 | $2.87M | Buy |
8,662
+4,614
| +114% | +$2.34M | 2.01% | 16 |
|
|
2019
Q1 | $2.53M | Buy |
4,048
+225
| +6% | +$103K | 1.67% | 16 |
|
|
2018
Q4 | $950K | Buy |
3,823
+18
| +0.5% | +$7.16K | 0.74% | 40 |
|
|
2018
Q3 | $1.77M | Buy |
3,805
+69
| +2% | +$33.4K | 1.06% | 28 |
|
|
2018
Q2 | $2.03M | Sell |
3,736
-129
| -3% | -$77.4K | 1.45% | 15 |
|
|
2018
Q1 | $2.21M | Sell |
3,865
-52
| -1% | -$32.8K | 1.99% | 8 |
|
|
2017
Q4 | $2.51M | Sell |
3,917
-65
| -2% | -$45.8K | 2.41% | 5 |
|
|
2017
Q3 | $3.75M | Sell |
3,982
-19
| -0.5% | -$14.5K | 3.93% | 3 |
|
|
2017
Q2 | $3.49M | Sell |
4,001
-412
| -9% | -$338K | 3.87% | 3 |
|
|
2017
Q1 | $3.04M | Buy |
4,413
+388
| +10% | +$256K | 3.14% | 6 |
|
|
2016
Q4 | $2.9M | Sell |
4,025
-5
| -0.1% | -$3.46K | 3.18% | 5 |
|
|
2016
Q3 | $2.97M | Sell |
4,030
-321
| -7% | -$260K | 2.97% | 5 |
|
|
2016
Q2 | $3.62M | Buy |
4,351
+1
| +0% | +$930 | 4.15% | 4 |
|
|
2016
Q1 | $3.59M | Sell |
4,350
-78
| -2% | -$61.3K | 4.5% | 3 |
|
|
2015
Q4 | $4.99M | Sell |
4,428
-9
| -0.2% | -$10.5K | 5.35% | 3 |
|
|
2015
Q3 | $3.76M | Buy |
4,437
+38
| +0.9% | +$55.1K | 4.19% | 3 |
|
|
2015
Q2 | $7.8M | Sell |
4,399
-1
| -0% | -$1.27K | 6.85% | 1 |
|
|
2015
Q1 | $5.29M | Buy |
4,400
+3
| +0.1% | +$3.51K | 4.43% | 2 |
|
|
2014
Q4 | $4.97M | Buy |
4,397
+7
| +0.2% | +$7.18K | 4.27% | 2 |
|
|
2014
Q3 | $4.41M | Sell |
4,390
-1,215
| -22% | -$1.37M | 3.73% | 2 |
|
|
2014
Q2 | $7.39M | Buy |
5,605
+64
| +1% | +$77K | 5.2% | 1 |
|
|
2014
Q1 | $7.72M | Sell |
5,541
-194
| -3% | -$252K | 5.41% | 1 |
|
|
2013
Q4 | $6.59M | Sell |
5,735
-18
| -0.3% | -$24.8K | 4.44% | 1 |
|
|
2013
Q3 | $7.21M | Sell |
5,753
-1,470
| -20% | -$998K | 5.19% | 1 |
|
|
2013
Q2 | $2.87M | Buy |
+7,223
| New | +$3.06M | 2.28% | 7 |
|
Other funds holding RMTI
VCM
VFT
WANY
Perkins Capital Management's RMTI Position: Q1 2026 in Review
Perkins Capital Management increased its Rockwell Medical (RMTI) stake by 3.7% in Q1 2026, buying an estimated $2.49K and bringing the position to 7,037 shares worth $62.9K. The position accounts for 0.06% of the portfolio, ranked #81.
Perkins Capital Management first reported a position in RMTI in Q2 2013 and has held it in 51 quarters since. The position peaked at $7.8M in Q2 2015. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.
- Perkins Capital Management held 7,037 shares of Rockwell Medical worth $62.9K as of Q1 2026.
- Perkins Capital Management bought 250 Rockwell Medical shares in Q1 2026, an estimated $2.49K.
- Rockwell Medical made up 0.06% of Perkins Capital Management's portfolio in Q1 2026, its #81 holding.
- Perkins Capital Management first reported a position in Rockwell Medical in Q2 2013 and has held it in 51 quarters since.
- Perkins Capital Management's Rockwell Medical position peaked at $7.8M in Q2 2015.
- 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.
Based on Perkins Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.